SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-058867
Filing Date
2023-12-15
Accepted
2023-12-15 18:29:33
Documents
1
Period of Report
2023-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5637
  Complete submission text file 0001209191-23-058867.txt   7110
Mailing Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247
Business Address 3060 PEGASUS PARK DRIVE BUILDING 6 DALLAS TX 75247 (310) 618-6994
Forte Biosciences, Inc. (Issuer) CIK: 0001419041 (see all company filings)

IRS No.: 261243872 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PFENEX INC. 10790 ROSELLE STREET SAN DIEGO CA 92121
Business Address
Wagner Paul A. (Reporting) CIK: 0001612842 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38052 | Film No.: 231491761